Free Trial

CytomX Therapeutics (CTMX) Insider Trading & Ownership

CytomX Therapeutics logo
$1.07 -0.02 (-1.83%)
(As of 12/24/2024 04:20 PM ET)

CytomX Therapeutics (NASDAQ:CTMX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$97,877.65
Get CTMX Insider Trade Alerts

Want to know when executives and insiders are buying or selling CytomX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CTMX Insider Buying and Selling by Quarter

CytomX Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/20/2024Christopher OgdenCFOSell1,984$1.23$2,440.32  
8/20/2024Jeffrey B LandauInsiderSell4,181$1.23$5,142.63  
8/20/2024Sean A MccarthyCEOSell13,898$1.23$17,094.54  
3/19/2024Christopher OgdenSVPSell2,971$2.09$6,209.39  
3/19/2024Jeffrey B LandauInsiderSell6,562$2.09$13,714.58  
3/19/2024Lloyd A RowlandGeneral CounselSell5,268$2.09$11,010.12  
3/19/2024Sean A MccarthyCEOSell20,223$2.09$42,266.07  
(Data available from 1/1/2013 forward)

CTMX Insider Trading Activity - Frequently Asked Questions

The list of insiders at CytomX Therapeutics includes Amy C Peterson, Carlos Campoy, Christopher Ogden, Elaine V Jones, Jeffrey B Landau, Lloyd A Rowland, Marcia Belvin, and Sean A Mccarthy. Learn more on insiders at CTMX.

7.00% of CytomX Therapeutics stock is owned by insiders. Learn more on CTMX's insider holdings.

The following insider purchased CTMX shares in the last 24 months: Elaine V Jones ($7,750.00).

Insiders have purchased a total of 5,000 CTMX shares in the last 24 months for a total of $7,750.00 bought.

The following insiders have sold CTMX shares in the last 24 months: Amy C Peterson ($8,428.86), Carlos Campoy ($3,461.04), Christopher Ogden ($9,671.39), Jeffrey B Landau ($18,857.21), Lloyd A Rowland ($22,175.18), Marcia Belvin ($10,980.96), and Sean A Mccarthy ($110,429.77).

Insiders have sold a total of 112,600 CytomX Therapeutics shares in the last 24 months for a total of $184,004.41 sold.

CytomX Therapeutics Key Executives

  • Dr. Sean A. McCarthy DPHIL (Age 57)
    Chairman & CEO
    Compensation: $1.03M


This page (NASDAQ:CTMX) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners